Back to the feed

US tracker

H.R. 3029

To amend the Research and Development, Competition, and Innovation Act to support nucleic acid screening, and for other purposes.

Commerce, Science, and Transportation Committee, Science, Space, and Technology Committee · Rep. Andrea Salinas (D-OR)

16 July 2026  |  Reported by committee (Science, Space, and Technology, H. Rept. 119-751)

What's next: Floor scheduling (leadership decides if and when it gets a vote)

Summary: The bill would require the National Institute of Standards and Technology (NIST) to develop best practices and technical standards for nucleic acid synthesis—the process of creating custom DNA and RNA used in medicines and agricultural products—to address biosecurity risks from potential misuse. It would direct NIST to conduct research on screening, operational security, and related topics, convene industry and stakeholder groups to establish consensus priorities, and advance safety standards for engineering biology and biomanufacturing, including risks from artificial intelligence.

[AI-Generated]

Sign in to vote or follow

Posted 10 September 2026

As published — the exact text this tracker posted, kept verbatim for the record
H.R. 3029 | To amend the Research and Development, Competition, and Innovation Act to support nucleic acid screening, and for other purposes. | Rep. Andrea Salinas (D-OR) | Commerce, Science, and Transportation Committee, Science, Space, and Technology Committee 📅 16 July 2026 | 📋 Reported by committee (Science, Space, and Technology, H. Rept. 119-751) What's next: Floor scheduling (leadership decides if and when it gets a vote) Summary: The bill would require the National Institute of Standards and Technology (NIST) to develop best practices and technical standards for nucleic acid synthesis—the process of creating custom DNA and RNA used in medicines and agricultural products—to address biosecurity risks from potential misuse. It would direct NIST to conduct research on screening, operational security, and related topics, convene industry and stakeholder groups to establish consensus priorities, and advance safety standards for engineering biology and biomanufacturing, including risks from artificial intelligence. [AI-Generated]

Look it up on Congress.gov See the full path of H.R. 3029

A permanent record of a post published by BillTracking's US tracker. The facts are drawn from the official record; the reference above is the lookup key on Congress.gov. Spotted an error? accuracy@billtracking.org.